Listed

Modular Medical, Inc.

MODDNasdaqCIK 1074871HealthcareFiscal year ends Mar 31

Latest reported revenue, Q3 FY2019$0Revenue, Q3 FY2019, three months to 2018-12-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2019-02-14, accession 0001019056-19-000143.Report this figureThree months to Dec 31, 2018, from the 10-Q filed Feb 14, 2019.

Latest quarter: Q1 FY2027

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenuenot reported (Revenue not reported)No year-earlier figure to compare
  • Gross marginnot reported (Gross profit and Revenue not reported)No year-earlier figure to compare
  • Operating marginnot reported (Revenue not reported)No year-earlier figure to compare
  • Net marginnot reported (Revenue not reported)No year-earlier figure to compare
  • Diluted EPS−$1.19Diluted EPS, Q1 FY2027, three months to 2026-06-30−$1.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure+67.8% on a year earlier
  • Free cash flow−$6.7mFree cash flow, Q1 FY2027, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$6.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Capital expenditure: $688.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure−5.6% on a year earlier

Last eight quarters

Full statements
Diluted EPS−$1.19, Q1 FY2027
Free cash flow−$6.7m, Q1 FY2027
Modular Medical, Inc., key figures for the last eight quarters
Line itemUnitQ2 FY20252024-09-30Q3 FY20252024-12-31Q4 FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q4 FY20262026-03-31Q1 FY20272026-06-30Shape over the periods
Revenue$knot reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)
Gross margin%not reported (Gross profit and Revenue not reported)not reported (Gross profit and Revenue not reported)not reported (Gross profit and Revenue not reported)not reported (Gross profit and Revenue not reported)not reported (Gross profit and Revenue not reported)not reported (Gross profit and Revenue not reported)not reported (Gross profit and Revenue not reported)not reported (Gross profit and Revenue not reported)
Operating margin%not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)
Net margin%not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)
Diluted EPS$ per share(0.14)Diluted EPS, Q2 FY2025, three months to 2024-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001213900-25-110819.Report this figure(0.13)Diluted EPS, Q3 FY2025, three months to 2024-12-31−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figurenot reported (Diluted EPS not reported)(3.70)Diluted EPS, Q1 FY2026, three months to 2025-06-30−$3.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure(0.14)Diluted EPS, Q2 FY2026, three months to 2025-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001213900-25-110819.Report this figure(0.11)Diluted EPS, Q3 FY2026, three months to 2025-12-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-17, accession 0001213900-26-017262.Report this figurenot reported (Diluted EPS not reported)(1.19)Diluted EPS, Q1 FY2027, three months to 2026-06-30−$1.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure
Free cash flow$k(3,927)Free cash flow, Q2 FY2025, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: −$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001213900-25-110819. Derived: 6-month figure less the 3-month figure.Capital expenditure: $161.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001213900-25-110819. Derived: 6-month figure less the 3-month figure.Report this figure(4,638)Free cash flow, Q3 FY2025, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$4.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-17, accession 0001213900-26-017262. Derived: 9-month figure less the 6-month figure.Capital expenditure: $542.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-17, accession 0001213900-26-017262. Derived: 9-month figure less the 6-month figure.Report this figure(5,258)Free cash flow, Q4 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$4.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-29, accession 0001213900-26-073223. Derived: 12-month figure less the 9-month figure.Capital expenditure: $948.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-29, accession 0001213900-26-073223. Derived: 12-month figure less the 9-month figure.Report this figure(6,306)Free cash flow, Q1 FY2026, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Capital expenditure: $934.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure(6,182)Free cash flow, Q2 FY2026, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: −$5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001213900-25-110819. Derived: 6-month figure less the 3-month figure.Capital expenditure: $771.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001213900-25-110819. Derived: 6-month figure less the 3-month figure.Report this figure(8,377)Free cash flow, Q3 FY2026, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-17, accession 0001213900-26-017262. Derived: 9-month figure less the 6-month figure.Capital expenditure: $1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-17, accession 0001213900-26-017262. Derived: 9-month figure less the 6-month figure.Report this figure(6,820)Free cash flow, Q4 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$5.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-29, accession 0001213900-26-073223. Derived: 12-month figure less the 9-month figure.Capital expenditure: $1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-29, accession 0001213900-26-073223. Derived: 12-month figure less the 9-month figure.Report this figure(6,660)Free cash flow, Q1 FY2027, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$6.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Capital expenditure: $688.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001213900-26-090301.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Diluted EPS−$12.36, FY2026
Free cash flow−$27.7m, FY2026
Modular Medical, Inc., key figures for the last five fiscal years
Line itemUnitFY20222022-03-31FY20232023-03-31FY20242024-03-31FY20252025-03-31FY20262026-03-31Shape over the periods
Revenue$mnot reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)
Gross margin%not reported (Gross profit and Revenue not reported)not reported (Gross profit and Revenue not reported)not reported (Gross profit and Revenue not reported)not reported (Gross profit and Revenue not reported)not reported (Gross profit and Revenue not reported)
Operating margin%not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)
Net margin%not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)not reported (Revenue not reported)
Diluted EPS$ per share(2.74)Diluted EPS, FY2022, twelve months to 2022-03-31−$2.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2023-06-26, accession 0001213900-23-051688.Report this figure(1.15)Diluted EPS, FY2023, twelve months to 2023-03-31−$1.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-06-21, accession 0001213900-24-054877.Report this figure(0.78)Diluted EPS, FY2024, twelve months to 2024-03-31−$0.78 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-06-20, accession 0001213900-25-055793.Report this figure(15.26)Diluted EPS, FY2025, twelve months to 2025-03-31−$15.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-06-29, accession 0001213900-26-073223.Report this figure(12.36)Diluted EPS, FY2026, twelve months to 2026-03-31−$12.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-06-29, accession 0001213900-26-073223.Report this figure
Free cash flow$m(10.3)Free cash flow, FY2022, twelve months to 2022-03-31. operating cash flow − capital expenditureOperating cash flow: −$10.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-06-26, accession 0001213900-23-051688.Capital expenditure: $54.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-06-26, accession 0001213900-23-051688.Report this figure(12.6)Free cash flow, FY2023, twelve months to 2023-03-31. operating cash flow − capital expenditureOperating cash flow: −$11.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-06-21, accession 0001213900-24-054877.Capital expenditure: $1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-06-21, accession 0001213900-24-054877.Report this figure(15.7)Free cash flow, FY2024, twelve months to 2024-03-31. operating cash flow − capital expenditureOperating cash flow: −$14.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-06-20, accession 0001213900-25-055793.Capital expenditure: $1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-06-20, accession 0001213900-25-055793.Report this figure(18.2)Free cash flow, FY2025, twelve months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$15.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-29, accession 0001213900-26-073223.Capital expenditure: $2.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-29, accession 0001213900-26-073223.Report this figure(27.7)Free cash flow, FY2026, twelve months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$23.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-29, accession 0001213900-26-073223.Capital expenditure: $3.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-29, accession 0001213900-26-073223.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Modular Medical, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
AWM Investment Company, Inc.2026-06-30$2.0m441,095Added+74,429
Solas Capital Management, LLC2026-06-30$2.0m438,095Added+150,000
Bleichroeder LP2026-06-30$1.5m336,986Added+150,000
683 Capital Management, LLC2026-06-30$585.0k130,000Added+4,999
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$464.3k103,182Added+47,265
BARD ASSOCIATES INC2026-06-30$457.8k101,744Added+2,254
NORTHERN TRUST CORP2026-06-30$280.5k62,331New+62,331
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$236.9k52,645Added+25,158
Sio Capital Management, LLC2026-06-30$117.9k26,190Unchanged
HighTower Advisors, LLC2026-06-30$89.2k19,825New+19,825

Recent filings

All 578 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Modular Medical, Inc., recent filings
FiledFormWhat it isAccession number
2026-10-2816:10 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001213900-26-113310
2026-10-0109:24 ETDEF 14AProxy statementPeriod 2026-10-230001213900-26-105495
2026-09-2916:10 ET8-K5.02 Departure or appointment of officers or directors0001213900-26-104656
2026-09-0317:15 ET8-K5.08 Item not in the standard list0001213900-26-097280
2026-08-1417:25 ET10-QQuarterly reportPeriod 2026-06-300001213900-26-090301
2026-06-2917:24 ET10-KAnnual reportPeriod 2026-03-310001213900-26-073223
2026-05-2016:30 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001213900-26-059557
2026-04-2112:20 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-26-045985
2026-04-1608:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-26-044343
2026-03-3116:35 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-26-037531

Latest annual report

Form 10-K for the fiscal year ended Mar 31, 2026Filed Jun 29, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
1074871
Tickers
MODD
Exchange
Nasdaq
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Mar 31
Incorporated in
NV
Filer category
Non-accelerated filer<br>Smaller reporting company
Former names
BEAR LAKE RECREATION INC (to 2017-05-25)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:11 ET. Listed shows no prices and gives no investment advice.